DCAT 2016 by Teva api

DCAT Week ’16: Focusing on the Future

By Kerri McCullough Wood, Vice President, Head of Global Teva api Sales 



The Teva api team was one of the many pharmaceutical developers, suppliers, manufacturers and leading researchers who converged on New York for DCAT Week ‘16 – the industry’s premier business development event.

During DCAT Week - we introduced 9 new pipline products in several disease categories.

Events DCAT Products North America

Organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), it provided the perfect setting for Teva api and other companies to meet with customers and suppliers, strengthen existing relationships and form new ones, announce new products and partnerships, and network with key decision makers. Attendees quickly learn how to make every minute count.

TAPI on DCAT 2016


This year the Teva api team – one of the largest contingents at DCAT Week – had nearly 150 meetings with customers during the four-day event. Through these face-to-face customer conversations, and as part of the customer experience Teva api provides to its customers, it was important for us to present a picture of the overall expertise, support and value. Customers had the opportunity to meet face-to-face with our representatives throughout the company:  from R&D, sales and  marketing to, supply chain, and more.  This kind of opportunity enabled customers to take advantage and collaborate closely with our experts and receive the needed information.   


It was a terrific opportunity to meet one-on-one with our customers, explore ways to collaborate more closely, learn how we can serve their needs better, along with ways to align their needs and expectations, and focus on our future together. 


Teva api made two exciting announcements during DCAT Week


First, we were pleased to introduce 9 new pipeline products in the following disease categories: 

Anti-cancer - Ixazomib and Venetoclax

Multiple Sclerosis - Monomethyl fumarate

CNS - Brexpiprazole

Ophthalmic - Latanoprostene bunod

Inhalation - Olodaterol


>>> Interested in one of our new products? Click on it's name to view details and to contact us with your inquiry!

We also  officially unveiled our re-designed website, teva-api.com, which offers some exciting new features, richer content, and a better user experience. Look for an upgrade to our customer portal, Teva api Online, later this year.


Teva api has been actively involved in DCAT for more than a decade. We are proud to support the association’s mission and have helped develop educational programs that share best practices and offer insights into industry trends. This year, I was honored to be recognized as outgoing Chair of the Education Committee, and look forward to continuing to serve the association with my recent appointment to the DCAT Board of Directors.


DCAT Week continues to be a valuable opportunity for pharmaceutical leaders to collaborate, network and learn from each other. Our team always comes home energized and inspired to create an even better experience for our customers. We’re already looking forward to next year and hope to see you in New York!



>>>Meet us at future events:

FCE Brazil – 10-12 May 2016

CPhI China – 21 – 23 June 2016